Trade VYNE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
VYNE Therapeutics Inc (VYNE) is trading at US$28.56, up 0.00% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$339.86K. Over the past 52 weeks, VYNE has traded between US$14.68 and US$46.95. On Syfe you can trade VYNE with $0 commission and add it to your watchlist.
| Previous close | US$28.56 |
|---|---|
| Market cap | US$339.86K |
| 52-week range | US$14.68 – US$46.95 |
| Volume | 93.25K |
| Exchange | US |
Add to Watchlist
Set Price Alert
VYNE Therapeutics Inc
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Stewartsville, NJ.
Year: 2018
Top Premarket Decliners
Jul 24, 11:43 AM · MT Newswires
VYNE Approves 1-for-50 Reverse Stock Split
Jul 21, 12:37 PM · MT Newswires
VYNE Therapeutics Declares Estimated $0.38-Per-Share Special Cash Dividend Ahead of Yarrow Merger
Jul 10, 12:33 PM · MT Newswires
VYNE Therapeutics Inc (VYNE) stock is trading at US$28.56, 0.00% from the previous close of US$28.56.
The market cap for VYNE Therapeutics Inc (VYNE) stock is approximately US$339.86K.
The 52-week high for VYNE Therapeutics Inc (VYNE) stock is US$46.95.
The 52-week low for VYNE Therapeutics Inc (VYNE) stock is US$14.68.
VYNE Therapeutics Inc (VYNE) does not currently pay a dividend.
Stay on top of VYNE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
